MELANIE STACEY: Open Payments
NPI 1184134520 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 40 payments from 13 companies in 2025. Trend: 2023 $773 · 2024 $950 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $228 |
| PFIZER INC. | 12 | $226 |
| Merck Sharp & Dohme LLC | 5 | $94 |
| Boston Scientific Corporation | 1 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Wegovy, VYNDAQEL, VERQUVO, WATCHMAN FLX, LEQVIO, JARDIANCE, FARXIGA, TRYNGOLZA.
Industry payments across AL — which companies pay providers there.
